HERAX Life Science

HERAX Life Science provides expert consulting services aimed at digital transformation in the life sciences, enhancing operational efficiency across research, regulatory affairs, and commercial operations. Founded in 2009 in Copenhagen, Denmark, HERAX Life Science specializes in consulting for life science companies, focusing on R&D IT strategies and business process optimization. The firm has not reported any significant changes in its business strategy or structure since its founding. HERAX has completed one deal as of February 24, 2025.

The company was established by a team of experienced professionals in the life sciences sector, though specific founder details are not disclosed. HERAX Life Science offers a comprehensive suite of consulting services primarily focused on aiding life science companies in the digital transformation of their business processes. Their main offerings include the development of R&D IT strategies, requirement definitions, and the selection and implementation of tailored IT systems and business processes. These services are designed to enhance operational efficiency across all stages of research and development, regulatory affairs, and commercial operations.

Serving a diverse client base that includes pharmaceutical, biotech, and medical device companies, HERAX provides extensive industry expertise through a team of over 30 specialized consultants. The company operates in various geographical markets, including Europe and North America, ensuring that it addresses the specific needs and regulatory environments of its clients. HERAX Life Science generates revenue through a consulting model that emphasizes partnerships and project-based engagements with its clients. The firm typically collaborates with companies on a contractual basis, structuring transactions around service agreements tailored to specific project needs.

Revenue is derived from consulting fees associated with their flagship services, which include project execution, operational change management, and training solutions. HERAX's pricing structure is aligned with the scope and complexity of each engagement, with fees determined based on the duration and resources allocated to each project. This approach enables HERAX to maintain flexible, client-centric service offerings that adapt to the unique challenges faced by organizations within the life sciences sector. In February 2025, HERAX Life Science was acquired by Groupe ProductLife S.

A. S. , a portfolio company of 21 Invest, and Oakley Capital Private Equity. This acquisition will enable HERAX to expand its life science consulting expertise, particularly in R&D digitization and technology solutions, strengthening its presence in the Nordics and globally.

The integration of resources is expected to support the development of new products tailored to client needs and enhance the firm's capabilities in existing markets.